Работы, на которые ссылается эта работа

Работ: 125

Работа: Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins

1. Cancer Stem Cell Metabolism

   Fidelia B. Alvina, Arvin M. Gouw, Anne Le

   Статья2021Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.830940

2. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy

   X. Xia, Zongxin Yang, Qisi Lu +6

   Обзорная статья2024Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.102984

3. Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors

   Parnaz Merikhian, Behrad Darvishi, Neda Jalili +10

   Статья2021Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.236591

4. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

   Taniya Saha, Kiven Erique Lukong

   Обзорная статья2022Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.279830

5. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy

   Asha Borah, Sreejith Raveendran, Ankit Rochani +2

   Обзорная статья2015Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.315345

6. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

   Erik Ames, Robert J. Canter, Steven K. Grossenbacher +11

   Статья2015Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.340825

7. Cancer stem cells

   Zuoren Yu, Timothy G. Pestell, Michael P. Lisanti +1

   Обзорная статья2012Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.340836

8. Overcoming Antigen Escape with CAR T-cell Therapy

   Hollie J. Jackson, Renier J. Brentjens

   Другое2015Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.340845

9. Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model

   Juan Fu, Yuhong Shang, Qian Zhang +5

   Статья2020Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.340874

10. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    Koichi Hirabayashi, Hongwei Du, Yang Xu +8

    Статья2021Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340879

11. Circulating tumor cells in neuroblastoma: Current status and future perspectives

    Ran Yang, Shan Zheng, Rui Dong

    Обзорная статья2022Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340892

12. Co-opting signalling molecules enables logic-gated control of CAR T cells

    Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh +15

    Статья2023Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340905

13. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

    Yufei Wang, Alicia Buck, Brandon Piel +26

    Статья2024Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340916

14. Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

    James J. Wu, Armin Ghobadi, Richard T. Maziarz +6

    Статья2024Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340920

15. Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing

    J. H. Isaacson, Prajakta Bhanap, Nicholas H. Putnam +7

    Статья2025Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340948

16. Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives

    Sarkar Sardar Azeez, Raya Kh. Yashooa, Shukur Wasman Smail +4

    Обзорная статья2025Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340951

17. Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy

    Gyas Khan, Ali Hanbashi, Wedad Mawkili +7

    Статья2025Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.340954

18. The Investigation of Nfκb Inhibitors to Block Cell Proliferation in OSCC Cells Lines

    Yuxi Cheng, Liping Wang, Shuju Zhang +4

    Статья2024Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.422036

19. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

    Changsong Qi, Chang Liu, Jifang Gong +21

    Статья2024Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.431628

20. Limits of CD133 as a marker of glioma self‐renewing cells

    Virginie Clément, Valérie Dutoit, Denis Marino +2

    Статья2009Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.593512

21. Role of TRPM2 in brain tumours and potential as a drug target

    Delphine Ji, Zhengwei Luo, Andrea Ovcjak +4

    Обзорная статья2021Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.806190

22. Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

    Franca Maria Tuccillo, Annamaria de Laurentiis, Camillo Palmieri +8

    Обзорная статья2014Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.830917

23. Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers

    Sylvain Julien, Aleksandar Ívetic, Anita Grigoriadis +11

    Статья2011Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.830920

24. Biology and clinical relevance of EpCAM

    Laura Keller, Stefan Werner, Klaus Pantel

    Обзорная статья2019Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.830933

25. The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

    Jung‐Tung Hung, I‐Ju Chen, Shir‐Hwa Ueng +8

    Статья2022Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.830952